Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRS-V: Actinomycin D and Vincristine +/- Radiation for Low-Risk Rhabdomyosarcoma
NCT00002995Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Aug 1997
- Primary completion
- Sep 2006
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of actinomycin D, vincristine in rhabdomyosarcoma (RMS), sponsored by Children's Oncology Group. Started Aug 1997; status: completed.
02
Drugs
actinomycin Dvincristine
03
Conditions
rhabdomyosarcoma (RMS)
Beyond the preview
Go deeper on NCT00002995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002995.